Banks are kicking off the fourth-quarter 2024 earnings season with a bang, with JPMorgan Chase (NYSE: JPM), Bank of America ...
China-based Ascentage Pharma said on Tuesday it was targeting a valuation of $1.75 billion in its initial public offering in the United States. Ascentage, backed by Japan's biggest drugmaker Takeda ...
Citi analyst Jenny Ping upgraded National Grid (NGG) to Buy from Neutral following a period of share price underperformance, ...